Literature DB >> 32978771

An overview of applications of CRISPR-Cas technologies in biomedical engineering.

Saleh Jamehdor1,2,3, Kasra Arbabi Zaboli4, Sina Naserian5,6, Jose Thekkiniath7, Honey Alef Omidy8, Ali Teimoori1, Behrooz Johari4, Amir Hossein Taromchi4, Yu Sasano9, Saeed Kaboli4.   

Abstract

Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR) is one of the major genome editing systems and allows changing DNA levels of an organism. Among several CRISPR categories, the CRISPR-Cas9 system has shown a remarkable progression rate over its lifetime. Recently, other tools including CRISPR-Cas12 and CRISPR-Cas13 have been introduced. CRISPR-Cas9 system has played a key role in the industrial cell factory's production and improved our understanding of genome function. Additionally, this system has been used as one of the major genome editing systems for the diagnosis and treatment of several infectious and non-infectious diseases. In this review, we discuss CRISPR biology, its versatility, and its application in biomedical engineering.

Entities:  

Keywords:  CRISPR-Cas12; CRISPR-Cas13; CRISPR-Cas9; Genome editing; sgRNA

Mesh:

Year:  2020        PMID: 32978771     DOI: 10.5603/FHC.a2020.0023

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  2 in total

Review 1.  Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer.

Authors:  Shreyasi Maity; Rishyani Mukherjee; Satarupa Banerjee
Journal:  Mol Biotechnol       Date:  2022-08-23       Impact factor: 2.860

Review 2.  Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review).

Authors:  Julija Dronina; Urte Samukaite-Bubniene; Arunas Ramanavicius
Journal:  J Nanobiotechnology       Date:  2022-01-21       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.